BioNexus Gene Lab Corp. has completed an IPO in the amount of $5 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 1,250,000
PriceRange: $4
Discount Per Security: $0.32
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.592 USD | +2.05% | -2.19% | +10.40% |
16/04 | BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
29/02 | BioNexus Gene Lab Corp. Provides Information to Shareholders | CI |
1st Jan change | Capi. | |
---|---|---|
+10.40% | 10.25M | |
+29.77% | 48.16B | |
-0.63% | 41.73B | |
+43.51% | 41.03B | |
-5.31% | 28.77B | |
+10.60% | 25.59B | |
-21.63% | 18.96B | |
+8.04% | 12.92B | |
+27.50% | 12.03B | |
-3.20% | 11.77B |